טוען...
T-cell activation is enhanced by targeting IL-10 cytokine production in toll-like receptor-stimulated macrophages
Toll-like receptor (TLR) agonists represent potentially useful cancer vaccine adjuvants in their ability to stimulate antigen-presenting cells (APCs) and subsequently amplify the cytotoxic T-cell response. The purpose of this study was to characterize APC responses to TLR activation and to determine...
שמור ב:
| הוצא לאור ב: | Immunotargets Ther |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dove Medical Press
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4934151/ https://ncbi.nlm.nih.gov/pubmed/27471682 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S32615 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|